Results 11 to 20 of about 468,836 (265)
Judicious use of medicines that considers evidence-based practice, together with cost-effectiveness, is a priority for all health care organisations. We describe an initiative to lead a Medication Utilisation Program, incorporating medication quality ...
Karen Whitfield +3 more
doaj +1 more source
Neonatal pharmacology and clinical implications
During the neonatal period, there is physiological immaturity of organs, systems and metabolic pathways that influences the pharmacokinetics and pharmacodynamics of administered drugs, the dosage of which should be constantly amended, considering the ...
Antonio Ruggiero +5 more
doaj +1 more source
This review firstly examines the underlying pathophysiology of pain and inflammation associated with orthopedic disease and endotoxemia. Then, it reviews the clinical pharmacology (pharmacokinetics and pharmacodynamics) of both conventional and non ...
Melissa A. Mercer +2 more
doaj +1 more source
Guduchi (Tinospora cordifolia) is a well-recognized and widely distributed traditional plant that is used successfully in Indian Ayurveda medicine. T.
Muhammad Saeed +12 more
doaj +1 more source
Effectiveness of Revised Pharmacology Record Books as a Teaching-Learning Method for Second Year Medical Students [PDF]
Introduction: The goal of teaching medical undergraduates Pharmacology is to form a sound foundation of therapeutics. The pharmacology record books are maintained as a part of the curriculum.
Dhanya Sasidharan Palappallil +1 more
doaj +1 more source
Effect of severe renal impairment on pharmacokinetics, safety, and tolerability of lemborexant
The primary aim of this study was to examine the effect of severe renal impairment (SRI) on the pharmacokinetics of lemborexant, a dual orexin receptor antagonist indicated for the treatment of insomnia.
Ishani Landry +6 more
doaj +1 more source
Integrating pharmacology and clinical pharmacology [PDF]
I here reaffirm some of the points that I made in the manifesto for UK clinical pharmacology [1], in response to letters from others. Much of what I wrote in the manifesto addresses points that correspondents have made, but as some of the important points may not have been clear on a first reading, I shall reiterate them and add clarifications. I am
openaire +2 more sources
Clinical Pharmacology of Sisomicin [PDF]
Studies were conducted in 30 patients with neoplastic diseases. Twelve patients received sisomicin intramuscularly at doses of 20 mg/m 2 and 40 mg/m 2 . The mean peak serum concentration occurred at 1 h and was 2.5 μg/ml and 4.0 μg/ml, respectively. Ten patients received intravenous sisomicin
V, Rodriguez +3 more
openaire +2 more sources
Where are the Ambulatory Care Pediatric Pharmacists?
This editorial describes the purposes and content of the Special Issue for the development of a national pediatric pharmacotherapy collaborative practice network.
Richard H. Parrish +2 more
doaj +1 more source
Background: Medication communication from physicians to patients often is poor, by this among others enhancing the risk of non-adherence. In this context, a neglect regarding the prescription talk has been complained.Aim of the project: In a newly ...
Hauser, Katarina +5 more
doaj +1 more source

